Literature DB >> 12598605

Neuronal hyperpolarization-activated pacemaker channels drive neuropathic pain.

Sandra R Chaplan1, Hong-Qing Guo, Doo Hyun Lee, Lin Luo, Changlu Liu, Chester Kuei, Alexander A Velumian, Matthew P Butler, Sean M Brown, Adrienne E Dubin.   

Abstract

Neuropathic pain is a common and often incapacitating clinical problem for which little useful therapy is presently available. Painful peripheral neuropathies can have many etiologies, among which are trauma, viral infections, exposure to radiation or chemotherapy, and metabolic or autoimmune diseases. Sufferers generally experience both pain at rest and exaggerated, painful sensitivity to light touch. Spontaneous firing of injured nerves is believed to play a critical role in the induction and maintenance of neuropathic pain syndromes. Using a well characterized nerve ligation model in the rat, we demonstrate that hyperpolarization-activated, cyclic nucleotide-modulated (HCN) "pacemaker" channels play a previously unrecognized role in both touch-related pain and spontaneous neuronal discharge originating in the damaged dorsal root ganglion. HCN channels, particularly HCN1, are abundantly expressed in rat primary afferent somata. Nerve injury markedly increases pacemaker currents in large-diameter dorsal root ganglion neurons and results in pacemaker-driven spontaneous action potentials in the ligated nerve. Pharmacological blockade of HCN activity using the specific inhibitor ZD7288 reverses abnormal hypersensitivity to light touch and decreases the firing frequency of ectopic discharges originating in Abeta and Adelta fibers by 90 and 40%, respectively, without conduction blockade. These findings suggest novel insights into the molecular basis of pain and the possibility of new, specific, effective pharmacological therapies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12598605      PMCID: PMC6742242     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  104 in total

Review 1.  New and emerging pharmacological targets for neuropathic pain.

Authors:  Donald C Manning
Journal:  Curr Pain Headache Rep       Date:  2004-06

Review 2.  Exploring HCN channels as novel drug targets.

Authors:  Otilia Postea; Martin Biel
Journal:  Nat Rev Drug Discov       Date:  2011-11-18       Impact factor: 84.694

3.  The voltage dependence of I(h) in human myelinated axons.

Authors:  James Howells; Louise Trevillion; Hugh Bostock; David Burke
Journal:  J Physiol       Date:  2012-02-06       Impact factor: 5.182

4.  Inward rectifying channels as new targets for treatment.

Authors:  Satoshi Kuwabara
Journal:  J Physiol       Date:  2010-07-15       Impact factor: 5.182

5.  Properties of low-threshold motor axons in the human median nerve.

Authors:  Louise Trevillion; James Howells; Hugh Bostock; David Burke
Journal:  J Physiol       Date:  2010-05-17       Impact factor: 5.182

Review 6.  Regulation of recombinant and native hyperpolarization-activated cation channels.

Authors:  Samuel G A Frère; Mira Kuisle; Anita Lüthi
Journal:  Mol Neurobiol       Date:  2004-12       Impact factor: 5.590

Review 7.  [Mechanisms in the development of pain. Key issue in the periphery].

Authors:  C Konrad; M Schmelz
Journal:  Internist (Berl)       Date:  2005-10       Impact factor: 0.743

8.  ZD 7288, an HCN channel blocker, attenuates chronic visceral pain in irritable bowel syndrome-like rats.

Authors:  Yu Chen; Chun Lin; Ying Tang; Ai-Qin Chen; Cui-Ying Liu; Da-Li Lu
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

9.  Up-regulation of hyperpolarization-activated cyclic nucleotide-gated channel 3 (HCN3) by specific interaction with K+ channel tetramerization domain-containing protein 3 (KCTD3).

Authors:  Xiaochun Cao-Ehlker; Xiangang Zong; Verena Hammelmann; Christian Gruner; Stefanie Fenske; Stylianos Michalakis; Christian Wahl-Schott; Martin Biel
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

Review 10.  The pharmacology of cyclic nucleotide-gated channels: emerging from the darkness.

Authors:  R Lane Brown; Timothy Strassmaier; James D Brady; Jeffrey W Karpen
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.